Drug Trial Radar · NCT03160885
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
Last checked: Nov 20, 2026Latest source record: Mar 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
794
Actual
Start
Jun 12, 2017
Primary completion
Sep 4, 2018
Study completion Aug 14, 2019
Sponsor
- Lead sponsor
- LEO PharmaIndustry
- Sponsor type
- Industry
- First posted
- May 19, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary objective: To evaluate the efficacy of tralokinumab compared with placebo in treating moderate to severe atopic dermatitis (AD). Secondary objectives: To evaluate the efficacy of tralokinumab on severity and extent of AD, itch, and health related quality of life compared with placebo. Maintenance objective: To evaluate maintenance of effect with continued tralokinumab dosing up to 52 weeks compared to placebo for subjects achieving clinical response at Week 16.
Conditions
- Atopic Dermatitis
Interventions
TralokinumabDrug
Tralokinumab is a human recombinant monoclonal antibody of the IgG4 subclass that specifically binds to human IL-13 and blocks interaction with the IL-13 receptors. It is presented as a liquid formulation for subcutaneous (SC) administration
PlaceboDrug
Placebo contains the same excipients, in the same concentration only lacking tralokinumab
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subjects With Investigator's Global Assessment (IGA) Score of 0 (Clear) or 1 (Almost Clear) at Week 16.Time frame: At Week 16
- Subjects Achieving at Least 75% Reduction in Eczema Area and Severity Index [EASI].Time frame: At Week 16
Locations
115 sites in 9 countries. Site status is shown where the registry gives one.
Burke Pharmaceutical Research
Hot Springs, Arkansas
California dermatology
Encinitas, California
Advanced SkinCare Surgery & Med Center
Fullerton, California
USC Department of Dermatology
Los Angeles, California
Thiele Dermatology Specialists, Inc
Murrieta, California
Island Dermatology
Newport Beach, California
Therapeutics Clinical Research
San Diego, California
San Luis Dermatology and Laser Clinic
San Luis Obispo, California
Southern California Dermatology, Inc.
Santa Ana, California
Olympian Clinical Research
Clearwater, Florida
Spotlight Research Center, LLC
Miami, Florida
Private Practice - Dr. Tory P. Sullivan
North Miami Beach, Florida
Marietta Dermatology Clinical Research, Inc.
Marietta, Georgia
MedaPhase, Inc.
Newnan, Georgia
Northwestern University
Chicago, Illinois
RUSH University
Chicago, Illinois
Dawes-Fretzin Clinical Research Group, LLC
Indianapolis, Indiana
Kansas City Dermatology, PA
Overland Park, Kansas
Beacon Clinical Research
Quincy, Massachusetts
HFMC New Center One
Detroit, Michigan
The Grekin Skin Institute
Warren, Michigan
Respiratory Medicine Research Institute of Michigan, PLC
Ypsilanti, Michigan
Clinical Studies Group
Henderson, Nevada
Psoriasis Treatment Center of Central New Jersey
East Windsor, New Jersey
Corning Center for Clinical Research
Corning, New York
Icahn School of Medicine at Mount Sinai
New York, New York
Sadick Dermatology
New York, New York
Wake Forest University Health Sciences
Winston-Salem, North Carolina
University of Cincinnati Health Physicians Office
Cincinnati, Ohio
Wright State Physicians
Fairborn, Ohio
Aventiv Research Inc.
Westerville, Ohio
Oregon Dermatology and Research Center
Portland, Oregon
Paddington Testing Company, Inc.
Philadelphia, Pennsylvania
Yardley Dermatology Associates
Yardley, Pennsylvania
Clinical Research Center of the Carolinas
Charleston, South Carolina
Rivergate Dermatology Clinical Research Center
Goodlettsville, Tennessee
Bellaire Dermatology Associates
Bellaire, Texas
Modern Research Associates, PLLC
Dallas, Texas
Austin Institute for Clinical Research, Inc.
Pflugerville, Texas
Progressive Clinical Research
San Antonio, Texas
Showing 40 of 115 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.